ArticleLife (Basel, Switzerland)2026

Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study.

Humera Banu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.